1. Home
  2. NCNA vs ASTI Comparison

NCNA vs ASTI Comparison

Compare NCNA & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNA
  • ASTI
  • Stock Information
  • Founded
  • NCNA 1997
  • ASTI 2005
  • Country
  • NCNA United Kingdom
  • ASTI United States
  • Employees
  • NCNA N/A
  • ASTI N/A
  • Industry
  • NCNA Biotechnology: Pharmaceutical Preparations
  • ASTI Semiconductors
  • Sector
  • NCNA Health Care
  • ASTI Technology
  • Exchange
  • NCNA Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • NCNA 4.3M
  • ASTI 4.3M
  • IPO Year
  • NCNA 2017
  • ASTI N/A
  • Fundamental
  • Price
  • NCNA $1.14
  • ASTI $2.65
  • Analyst Decision
  • NCNA Buy
  • ASTI
  • Analyst Count
  • NCNA 2
  • ASTI 0
  • Target Price
  • NCNA $25.00
  • ASTI N/A
  • AVG Volume (30 Days)
  • NCNA 238.3K
  • ASTI 120.4K
  • Earning Date
  • NCNA 11-25-2024
  • ASTI 02-19-2025
  • Dividend Yield
  • NCNA N/A
  • ASTI N/A
  • EPS Growth
  • NCNA N/A
  • ASTI N/A
  • EPS
  • NCNA N/A
  • ASTI N/A
  • Revenue
  • NCNA N/A
  • ASTI $44,673.00
  • Revenue This Year
  • NCNA N/A
  • ASTI N/A
  • Revenue Next Year
  • NCNA N/A
  • ASTI N/A
  • P/E Ratio
  • NCNA N/A
  • ASTI N/A
  • Revenue Growth
  • NCNA N/A
  • ASTI N/A
  • 52 Week Low
  • NCNA $0.96
  • ASTI $2.25
  • 52 Week High
  • NCNA $19.40
  • ASTI $87.80
  • Technical
  • Relative Strength Index (RSI)
  • NCNA 43.15
  • ASTI 47.29
  • Support Level
  • NCNA $0.96
  • ASTI $2.49
  • Resistance Level
  • NCNA $1.37
  • ASTI $2.78
  • Average True Range (ATR)
  • NCNA 0.15
  • ASTI 0.40
  • MACD
  • NCNA -0.00
  • ASTI -0.05
  • Stochastic Oscillator
  • NCNA 26.09
  • ASTI 10.20

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: